lncRNA RAET1K Promotes the Progression of Acute Myeloid Leukemia by Targeting miR-503-5p/INPP4B Axis

References

• Bullinger L, Döhner K, Döhner H. Genomics of acute myeloid leukemia diagnosis and pathways. J Clin Oncol. 2017;35(9):934–946. doi:10.1200/JCO.2016.71.2208
   PubMed Web of Science ®Google Scholar
• Bose P, Vachhani P, Cortes JE. Treatment of relapsed/refractory acute myeloid leukemia. Curr Treat Options Oncol. 2017;18(3):17. doi:10.1007/s11864-017-0456-2
   PubMed Web of Science ®Google Scholar
• Döhner H, Weisdorf DJ, Bloomfield CD, Longo DL. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152. doi:10.1056/NEJMra1406184
   PubMed Web of Science ®Google Scholar
• Wang WT, Ye H, Wei PP, et al. LncRNAs H19 and HULC, activated by oxidative stress, promote cell migration and invasion in cholangiocarcinoma through a ceRNA manner. J Hematol Oncol. 2016;9:117.
   PubMed Web of Science ®Google Scholar
• Bartonicek N, Maag JL, Dinger ME. Long noncoding RNAs in cancer: mechanisms of action and technological advancements. Mol Cancer. 2016;15:43.
   PubMed Web of Science ®Google Scholar
• Qian X, Zhao J, Yeung PY, Zhang QC, Kwok CK. Revealing lncRNA structures and interactions by sequencing-based approaches. Trends Biochem Sci. 2019;44:33–52.
   PubMed Web of Science ®Google Scholar
• Huang HW, Xie H, Ma X, Zhao F, Gao Y. Upregulation of LncRNA PANDAR predicts poor prognosis and promotes cell proliferation in cervical cancer. Eur Rev Med Pharmacol Sci. 2017;21:4529–4535.
   PubMed Web of Science ®Google Scholar
• Wang MW, Liu J, Liu Q, et al. LncRNA SNHG7 promotes the proliferation and inhibits apoptosis of gastric cancer cells by repressing the P15 and P16 expression. Eur Rev Med Pharmacol Sci. 2017;21:4613–4622.
   PubMed Web of Science ®Google Scholar
• Zhu FF, Zheng FY, Wang HO, Zheng JJ, Zhang Q. Downregulation of lncRNA TUBA4B is associated with poor prognosis for epithelial ovarian cancer. Pathol Oncol Res. 2018;24:419–425.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Huang Y, Hu K, Zhang Z, Yang J, Wang Z. HIF1A activates the transcription of lncRNA RAET1K to modulate hypoxia-induced glycolysis in hepatocellular carcinoma cells via miR-100-5p. Cell Death Dis. 2020;11(3):176. doi:10.1038/s41419-020-2366-7
   PubMed Web of Science ®Google Scholar
• Zheng C, Li X, Ren Y, Yin Z, Zhou B. Long noncoding RNA RAET1K enhances CCNE1 expression and cell cycle arrest of lung adenocarcinoma cell by sponging miRNA-135a-5p. Front Genet. 2020;10:1348. doi:10.3389/fgene.2019.01348
   PubMed Web of Science ®Google Scholar
• Orso F, Quirico L, Dettori D, et al. Role of miRNAs in tumor and endothelial cell interactions during tumor progression. Semin Cancer Biol. 2020;60:214–224. doi:10.1016/j.semcancer.2019.07.024
   PubMed Web of Science ®Google Scholar
• Liu L, Ren W, Chen K. MiR-34a promotes apoptosis and inhibits autophagy by targeting HMGB1 in acute myeloid leukemia cells. Cell Physiol Biochem. 2017;41(5):1981–1992. doi:10.1159/000475277
   PubMedGoogle Scholar
• Ding C, Chen S-N, Macleod RAF, et al. MiR-130a is aberrantly overexpressed in adult acute myeloid leukemia with t(8;21) and its suppression induces AML cell death. Ups J Med Sci. 2018;123(1):19–27. doi:10.1080/03009734.2018.1440037
   PubMed Web of Science ®Google Scholar
• Ding Q, Wang Q, Ren Y, Zhu HQ, Huang Z. MicroRNA-126 attenuates cell apoptosis by targeting TRAF7 in acute myeloid leukemia cells. Biochem Cell Biol. 2018;96(6):840–846. doi:10.1139/bcb-2018-0017
   PubMed Web of Science ®Google Scholar
• Jiang SP, Li ZR. MiR-503-5p regulates cell epithelial-to-mesenchymal transition, metastasis and prognosis of hepatocellular carcinoma through inhibiting WEE1. Eur Rev Med Pharmacol Sci. 2019;23:2028–2037.
   PubMed Web of Science ®Google Scholar
• Sun Y, Li L, Xing S, et al. miR-503-3p induces apoptosis of lung cancer cells by regulating p21 and CDK4 expression. Cancer Biomarkers. 2017;20(4):597–608. doi:10.3233/CBM-170585
   PubMed Web of Science ®Google Scholar
• Sun Q, Li Q, Xie F. LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p. Oncotargets Ther. 2019;12:6297–6307. doi:10.2147/OTT.S214689
   PubMed Web of Science ®Google Scholar
• Gasser JA, Inuzuka H, Lau AW, Wei W, Beroukhim R, Toker A. SGK3 mediates INPP4B-dependent PI3K signaling in breast cancer. Mol Cell. 2014;56(4):595–607. doi:10.1016/j.molcel.2014.09.023
   PubMed Web of Science ®Google Scholar
• Min JW, Kim KI, Kim H-A, et al. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells. Biochem Biophys Res Commun. 2013;440(1):137–142. doi:10.1016/j.bbrc.2013.09.041
   PubMed Web of Science ®Google Scholar
• Chen L, Cao Y, Rong D, Wang Y, Cao Y. MicroRNA-605 functions as a tumor suppressor by targeting INPP4B in melanoma. Oncol Rep. 2017;38(2):1276–1286. doi:10.3892/or.2017.5740
   PubMed Web of Science ®Google Scholar
• Rijal S, Fleming S, Cummings N, et al. Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML. Blood. 2015;125(18):2815–2824. doi:10.1182/blood-2014-09-603555
   PubMed Web of Science ®Google Scholar
• Dzneladze I, He R, Woolley JF, et al. INPP4B overexpression is associated with poor clinical outcome and therapy resistance in acute myeloid leukemia. Leukemia. 2015;29:1485–1495.
   PubMed Web of Science ®Google Scholar
• Wang Y, Zhou Q, Ma JJ. High expression of lnc-CRNDE presents as a biomarker for acute myeloid leukemia and promotes the malignant progression in acute myeloid leukemia cell line U937. Eur Rev Med Pharmacol Sci. 2018;22:763–770.
   PubMed Web of Science ®Google Scholar
• Li G, Zheng P, Wang H, Ai Y, Mao X. Long non-coding RNA TUG1 modulates proliferation, migration, and invasion of acute myeloid leukemia cells via regulating miR-370-3p/MAPK1/ERK. Onco Targets Ther. 2019;12:10375–10388.
   PubMed Web of Science ®Google Scholar
• Hao X, Shin MS, Zhou JX, et al. Histologic and molecular characterizations of megakaryocytic leukemia in mice. Leuk Res. 2006;30(4):397–406. doi:10.1016/j.leukres.2005.08.021
   PubMed Web of Science ®Google Scholar
• Zhao TT, Liu X. LncRNA-H19 inhibits apoptosis of acute myeloid leukemia cells via targeting miR-29a-3p. Eur Rev Med Pharmacol Sci. 2019;23:224–231.
   PubMedGoogle Scholar
• Shi J, Dai R, Chen Y, Guo H, Han Y, Zhang Y. LncRNA LINP1 regulates acute myeloid leukemia progression via HNF4α/AMPK/WNT5A signaling pathway. Hematol Oncol. 2019;37(4):474–482. doi:10.1002/hon.2651
   PubMed Web of Science ®Google Scholar
• Wang C-H, Li Q-Y, Nie L, Ma J, Yao C-J, Chen F-P. LncRNA ANRIL promotes cell proliferation, migration and invasion during acute myeloid leukemia pathogenesis via negatively regulating miR-34a. Int J Biochem Cell Biol. 2020;119:105666. doi:10.1016/j.biocel.2019.105666
   PubMed Web of Science ®Google Scholar
• Sun H, Sun Y, Chen Q, Xu Z. LncRNA KCNQ1OT1 contributes to the progression and chemoresistance in acute myeloid leukemia by modulating Tspan3 through suppressing miR-193a-3p. Life Sci. 2020;241:117161. doi:10.1016/j.lfs.2019.117161
   PubMed Web of Science ®Google Scholar
• Peng L, Zhang Y. lncRNA SNHG3 facilitates acute myeloid leukemia cell growth via the regulation of miR-758-3p/SRGN axis. J Cell Biochem. 2020;121:1023–1031.
   PubMed Web of Science ®Google Scholar
• Akhade VS, Pal D, Kanduri C. Long noncoding RNA: genome organization and mechanism of action. Adv Exp Med Biol. 2017;1008:47–74.
   PubMed Web of Science ®Google Scholar
• Ran W, Zeng YH, Ma XJ, Liao P, Liu XL. [The effect of miR-503-5p on the proliferation, invasion, migration and epithelial interstitium of cervical cancer HeLa cells via targeting E2 F3]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2020;51:178–184.
   PubMedGoogle Scholar
• De Mariano M, Stigliani S, Moretti S, et al. A genome-wide microRNA profiling indicates miR-424-5p and miR-503-5p as regulators of ALK expression in neuroblastoma. Oncotarget. 2017;8:56518–56532.
   PubMedGoogle Scholar
• Cai X, Nie J, Chen L, Yu F. Circ_0000267 promotes gastric cancer progression via sponging MiR-503-5p and regulating HMGA2 expression. Mol Genet Genomic Med. 2020;8:e1093.
   PubMed Web of Science ®Google Scholar
• Recher C. INPP4B, a new player in the chemoresistance of AML. Blood. 2015;125:2738–2739.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zeng D, Chen Y, et al. miR-937 contributes to the lung cancer cell proliferation by targeting INPP4B. Life Sci. 2016;155:110–115.
   PubMed Web of Science ®Google Scholar
• Ma Q, Wang Y, Zhang H, Wang F. miR-1290 contributes to colorectal cancer cell proliferation by targeting INPP4B. Oncol Res. 2018;26:1167–1174.
   PubMed Web of Science ®Google Scholar
• Strotbek M, Schmid S, Sánchez-González I, Boerries M, Busch H, Olayioye MA. miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer. Int J Cancer. 2017;140:2310–2320.
   PubMed Web of Science ®Google Scholar
• Wei L, Sun C, Zhang Y, Han N, Sun S. miR-503-5p inhibits colon cancer tumorigenesis, angiogenesis, and lymphangiogenesis by directly downregulating VEGF-A. Gene Ther. 2020.
   Web of Science ®Google Scholar
• Li J, Zhang F, Li H, et al. Circ_0010220-mediated miR-503-5p/CDCA4 axis contributes to osteosarcoma progression tumorigenesis. Gene. 2020;763:145068.
   PubMed Web of Science ®Google Scholar